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Abstract: Arboviruses such as bluetongue virus (BTV) replicate in arthropod vectors involved in their
transmission between susceptible vertebrate-hosts. The “classical” BTV strains infect and replicate
effectively in cells of their insect-vectors (Culicoides biting-midges), as well as in those of their
mammalian-hosts (ruminants). However, in the last decade, some “atypical” BTV strains, belonging
to additional serotypes (e.g., BTV-26), have been found to replicate efficiently only in mammalian
cells, while their replication is severely restricted in Culicoides cells. Importantly, there is evidence
that these atypical BTV are transmitted by direct-contact between their mammalian hosts. Here, the
viral determinants and mechanisms restricting viral replication in Culicoides were investigated using
a classical BTV-1, an “atypical” BTV-26 and a BTV-1/BTV-26 reassortant virus, derived by reverse
genetics. Viruses containing the capsid of BTV-26 showed a reduced ability to attach to Culicoides
cells, blocking early steps of the replication cycle, while attachment and replication in mammalian
cells was not restricted. The replication of BTV-26 was also severely reduced in other arthropod cells,
derived from mosquitoes or ticks. The data presented identifies mechanisms and potential barriers
to infection and transmission by the newly emerged “atypical” BTV strains in Culicoides.
Keywords: arbovirus; bluetongue; BTV-26; atypical serotype; reverse genetics; cell binding; VP2
1. Introduction
Bluetongue virus (BTV) is the causative agent of ‘bluetongue’ (BT), a haemorrhagic
disease of domesticated and wild ruminants, although camelids and certain species of large
carnivores can also become infected [1–3]. Bluetongue is of high economic importance to
the agriculture sector, causing fatalities and production losses in livestock, and is notifiable
to the World Organization for Animal Health (OIE) [4].
Bluetongue virus is the type species of the genus Orbivirus, family Reoviridae. It has
an icosahedral capsid, approximately 80 nm in diameter, composed of three concentric
layers of proteins [5,6]. Twenty-four distinct BTV serotypes (BTV-1 to BTV-24) have been
recognised for many decades, the identity of which is determined by the specificity of
neutralising antibody interactions with their outer-capsid protein VP2 [7]. These ‘classical’
BTV strains are arthropod-borne viruses (arboviruses), transmitted between their ruminant
hosts primarily by adult Culicoides biting-midges (Diptera: Ceratopogonidae), although more
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rarely, transmission can also occur via transplacental transmission, or ingestion of infected
material [8–10].
BTV infects and replicates in its insect vectors, after ingestion as part of a blood meal
from an infected vertebrate host, resulting in internal dissemination and infection of the
insect salivary glands. This allows the virus to be transmitted to other hosts through
the insect’s saliva during subsequent blood meals. Consequently, the incidence of BTV
infections is directly linked to the global and seasonal distribution of vector-competent,
adult Culicoides populations. Currently, 1357 species of Culicoides have been described [11],
of which at least 13 different species have been implicated as BTV vectors (reviewed in [12]).
The geographic spread of BT outbreaks has recently expanded northwards, beyond
their historical distribution (between latitudes 40◦ S and 53◦ N), with the virus becoming
endemic in southern and central Europe [13,14]. These changes have been linked to
increased travel/trade and particularly the effects of climate change on the distribution
and seasonal activity of vector species/populations in the region.
Since 2008 several BTV strains have emerged that belong to previously unrecognized
serotypes, (including BTV-25, 26 and 27), as well as strains that have not yet been assigned
to specific serotypes [15,16]. Some of these novel viruses are adapted to small ruminants
(sheep and goats), causing asymptomatic infections, but are unable to replicate effectively
in adult Culicoides sonorensis, or in KC cells [17–20]. These atypical strains are believed to
be transmitted primarily by direct animal to animal contact [18,20,21].
The ability of an arthropod vector to become infected and subsequently transmit the
virus to a susceptible host determines its vector competence. This ability varies between
Culicoides species, and different levels of susceptibility to BTV infection are also observed
between individual insects of the same species, as well as between different strains of
BTV [22–25]. This indicates that host, virus and vector characteristics (genetic factors), as
well as different environmental variables can all be involved in determination of transmis-
sion efficiency, vector competence of individual insects and the overall vector capacity of
vector populations [26,27]. Some aspects of Culicoides-dependent vector-competence have
been studied (reviewed in [28]) and the role played by several of the viral proteins in the
replication of BTV in Culicoides cells has been shown in vitro and in vivo [19,29]. However,
in general, the determinants that control vector competence and the mechanisms involved
are poorly understood.
The genome of BTV comprises ten linear segments of double stranded (ds) RNA,
identified as segment 1 to 10 (Seg-1 to Seg-10) in order of decreasing molecular weight [6],
which collectively encode seven structural proteins (VP1 to VP7), and at least four non-
structural proteins (NS1 to NS4), plus a putative NS5 protein encoded by an additional
ORF in segment 10 [30–32]. Within the particle, each of the ten packaged dsRNA seg-
ments is associated with a transcriptase complex (TC) that consist of an RNA-dependent
RNA polymerase (VP1/Seg-1), a helicase (VP6/Seg-9) and a capping enzyme (VP4/Seg-
4) [5,33,34]. The innermost capsid shell (‘sub-core’), which surrounds and interacts with
both the genome segments and TCs, is composed of 120 copies of VP3 (encoded by Seg-3).
The intermediate ‘core surface’ layer contains 260 trimers of VP7 (encoded by Seg-7), which
interact with both the outer-capsid and the sub-core. The external ‘outer-capsid’ layer is
assembled from 60 trimers of VP2 (encoded by Seg-2) and 120 trimers of VP5 (encoded
by Seg-6).
In mammalian cells, the BTV outer-capsid is responsible for cell attachment, via
the interaction of VP2 and a still unknown receptor(s) on the cell surface, followed by
internalization/cell-membrane penetration mediated by VP5 [35–38]. The mechanisms
by which BTV initiates infection of Culicoides cells have been studied to a much lesser
extent than in mammalian cells. In addition to intact BTV virus-particles, particles with
protease-cleaved VP2 (infectious sub-viral particles—ISVP) and core particles that have lost
their outer capsid components, can also be highly infectious for the KC cell line (derived
from C. sonorensis) and for adult Culicoides via an oral route [39,40]. This suggests the
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use of multiple cell-attachment and entry mechanisms, involving VP2/VP5 or VP7, also
potentially utilizing different cell-surface receptors.
VP2 and to a lesser extent VP5, are the most variable of the BTV proteins [7]. The
amino-acid/nucleotide sequences of VP2/Seg-2 can be divided into distinct phylogenetic
clades, which correlate with BTV serotype [7]. To date, at least 27 distinct serotypes
have been recognized, which include the novel, ‘atypical’ BTV strains of BTV-25, -26 and
-27 [17,41,42]. Several additional putative novel BTV serotypes have also recently been
identified [15,43,44].
The ability of BTV-26 from Kuwait (isolate KUW2010/02) to replicate efficiently in
mammalian cells (for example BSR cells), but not in Culicoides cells, provides an opportunity
to study BTV-vector interactions. Reassortant viruses generated by reverse genetics, con-
taining a selection of genome-segments from BTV-26 and the reference strain of BTV-1, were
generated and used in our previous study to identify four genome segments of BTV-26 that
completely (Seg-1, encoding VP1—RNA-dependent-RNA-polymerase; Seg-2, encoding
VP2—outer-capsid protein; and Seg-3, encoding VP3—sub-core shell protein); or partially
(Seg-7, encoding VP7—outer-core protein) restrict replication in vitro in Culicoides derived
KC cells [19], while maintaining complete ability to infect and replicate in a mammalian
BSR cell line. Here we build on our previous work to initially investigate the ability of
BTV-26 to replicate in cells derived from other ‘potential’ arthropod-vectors, including both
mosquitoes and ticks as well as bovine host derived endothelial cells.
As cell binding and entry is a key factor in restricting virus host-cell range we, further-
more, specifically investigate the role of the outer capsid proteins of BTV-26 in preventing
infection of Culicoides-derived cells and adult vector Culicoides. We report binding and
replication studies using BTV-26 and a reassortment virus based on BTV-1, but containing
capsid proteins VP2, VP5 and VP7 of BTV-26, and identify that early stages of the BTV-26
replication cycle, including cell-attachment, are impeded in KC cells, but not in mammalian-
derived cells. This block cannot be overcome by higher MOIs or temperatures. Like the
BTV-26 wild-type, the reassortant virus is also incapable of replicating to transmissible
levels in adult female C. sonorensis midges, confirming that the capsid of BTV-26 is defective
in infecting midges, and greatly contributes to the overall inability of BTV-26 to efficiently
replicate and ‘amplify’ in Culicoides-derived cells or adult midges.
2. Materials and Methods
2.1. Viruses and Cells
The viruses used in this study were obtained from the dsRNA virus collection at The
Pirbright Institute (TPI) (Table 1). A ‘reverse engineered’ virus (rBTV-1) was generated
in BSR cells (a clone of baby hamster kidney cells BHK-21 [45], and obtained from Dr
Mark Boyce, The Pirbright Institute, Woking, UK), as already described [19], using mRNAs
derived from the reference strain for BTV serotype 1 (BTV-1, isolate (RSArrrr/01), originally
from South Africa). The reference strain for BTV-26 (KUW2010/02), (referred to as BTV-26),
was isolated from ovine blood samples from Kuwait [41]. The strain, rBTV-126 S2,S6,S7 was
‘reverse engineered’ containing genome-segments 2, 6 and 7 (Seg-2, 6 and 7) from BTV-26
(coding for the larger outer-capsid protein VP2, the smaller outer-capsid protein VP5 and
core-surface protein VP7 respectively), with the remaining genome-segments (the genetic
‘backbone’) from BTV-1 RSArrrr/01 [19] (Table 1). Virus stocks were generated in BSR cells.
Mammalian BSR and BFA cells (Bovine Foetal Aorta endothelium cells, catalogue num-
ber 87022601, European Collection of Authenticated Cell Cultures, Public Health England,
Porton Down, Salisbury, UK) were incubated at +37 ◦C with 5% CO2. BSR cells were grown
in Dulbecco’s modified Eagle medium (DMEM) GlutaMAX (Gibco® by Life Technologies
Limited, Paisley, UK) with 5% heat-inactivated foetal bovine serum (HI-FBS) (Gibco®
by Life Technologies Limited, Paisley, UK) and penicillin (100 U/mL)/streptomycin
(100 µg/mL) (1% Pen/Strep) (Gibco® by Life Technologies Limited, Paisley, UK). BFA
cells were grown in Nutrient Mixture F-12 Ham’s medium (Sigma-Aldrich®, Gillingham,
UK) with 10% HI-FBS and 1% Pen/Strep.
Viruses 2021, 13, 919 4 of 20
Table 1. List of viruses.
Virus
(ORC number) 1 Cell Passage History
2 Origin 3 Comments
BTV-1 (RSArrrr/01) E2, BHK9, BSR1 * Natural (TPI) Strain used for segment cloning, identified as wtBTV-1
BTV-26 (KUW2010/02) E1, BHK2, BSR1 Natural (TPI) Strain used for segment cloning and infections, identifiedas BTV-26
rBTV-1 (BTV-RV0023) BSR3 Synthetic Rescued strain, derived from BTV-1 RSArrrr/01cloned segments
rBTV-126 S2,S6,S7 (BTV-RV0020) BSR3 Synthetic
Rescued strain comprised of wtBTV-1 derived backbone,
with genome-segments 2, 6 and 7 derived from BTV-26
1 Orbivirus Reference Collection (ORC) number. Viruses available in the ORC at The Pirbright Institute (TPI): https://www.reoviridae.
org/dsRNA_virus_proteins/ReoID/BTV-isolates.htm (accessed on 14 May 2021). 2 Notation of cell passage history: E = passaged in
embryonated chicken eggs, BHK in Baby Hamster Kidney cells, BSR in a clone derived from BHK, as described in Section 2.2, together with
the number of passages in that cell line/system; 3 Synthetic viruses generated in [19] were obtained from the ORC at TPI; * Cell passage
history recorded at TPI upon obtaining of this virus isolate.
KC cells, originally derived from 2-day-old Culicoides sonorensis midge embryos [46]
(cell line maintained at the Pirbright Institute, Woking, UK, and originally provided by
Sally Wechsler, USDA Laramie, Laramie, WY, USA [39]), and U4.4 cells (derived from
Aedes albopictus mosquito larvae [47], obtained from Dr Sue Jacobs, TPI, Woking, UK) were
incubated at +28 ◦C without CO2. KC cells were grown in Schneider’s insect medium
(Sigma-Aldrich®, Gillingham, UK) with 10% HI-FBS and 1% Pen/Strep. U4.4 cells were
maintained with Leibowitz’s L-15 medium GlutaMAX™ (Gibco® by Life Technologies
Limited, Paisley, UK) with 10% HI-FBS, 2% Tryptose Phosphate Broth (TPB) (Sigma-
Aldrich®, Gillingham, UK) and 1% Pen/Strep.
Tick cells lines RAE25 (derived from Rhipicephalus appendiculatus tick embryos [48])
and HAE/CTVM9 (derived from Hyalomma anatolicum tick embryos [49]) were incubated
at +32 ◦C without CO2. RAE25 were maintained and provided ready to infect by Dr Lesley
Bell-Sakyi, University of Liverpool, Liverpool, UK.
2.2. Time-Course Experiments
Replication kinetics experiments were carried out in mammalian, insect and tick cell
lines. Except for the tick cells, these experiments were carried out in T25 cm2 flasks or
24-well plates (Corning® Costar®, Corning Inc., Corning, NY, USA). Cells were seeded
and incubated at their corresponding temperature overnight (Table 2). The following day,
cells were infected with BTV diluted in serum-free medium at a multiplicity of infection
(MOI) of 0.01, 1, or 5, depending on the experiment. Virus was allowed to adsorb at
room temperature for one hour. The inoculum was then removed, and cells washed three
times with Dulbecco’s phosphate buffered saline (DPBS) calcium and magnesium free
(Sigma-Aldrich®, Gillingham, UK). Six mL (for T25 cm2) or 1 mL (for 24-well plate) of
fresh maintenance medium (Table 2) was added in each flask/well. Supernatant samples
(250 µL) and/or coverslips were immediately collected, at 0 days post infection (0 dpi).
For infections carried out in T25 cm2 flasks, 250 µL of fresh ‘replacement’ medium was
added. For infections carried out in 24-well plates, one well was used per time point, and
cells were then incubated at appropriate temperatures (Table 2). Supernatant samples were
collected at selected times pi and stored at +4 ◦C until the end of the experiment, when RNA
was extracted from 100 µl of each sample using a Kingfisher™ Flex robot (Thermo Fisher
Scientific, Swindon, UK) and the LSI MagVet™ Universal Isolation Kit (Thermo Fisher
Scientific, Swindon, UK) as per manufacturer’s instructions. Virus copy numbers were
quantified using a BTV qRT-PCR assay targeting genome-segment 9 [50], with a 10-fold
serial dilution of Seg-9 RNA in vitro transcripts as standard. Coverslips were fixed for 1 h
in 4% paraformaldehyde (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) immediately
after collection and kept in PBS at +4 ◦C until processed for immunofluorescence staining.
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Table 2. Cell culture conditions during virus infection.
Cell Line No. of Seeded Cells Incubation (◦C) Maintenance Medium
BSR 1 × 10
5 cells/well (24 well plate)
3 × 106 cells/flask (T25 cm2 flask)
37 ± 1
with 5% CO2
DMEM GlutaMAX™ + 1% HI-FBS + 1% Pen/Strep
BFA 1 × 105 cells/well (24 well plate) 37 ± 1with 5% CO2
Nutrient Mixture F-12 Ham’s medium + 1% HI-FBS +
1% Pen/Strep
KC 7 × 10
5 cells/well (24 well plate)
2.5 × 107 cells/flask (T25 cm2 flask)
27 ± 1
without CO2
Schneider’s insect medium + 10% HI-FBS + 1%
Pen/Strep
U4.4 2.5 × 107 cells/flask (T25 cm2 flask) 27 ± 1without CO2
Leibowitz’s L-15 GlutaMAX™ + 10% HI-FBS + 2%
TPB + 1% Pen/Strep
RAE25 2.4 × 106 cells/tube (5.5 cm2 flat-sided tubes) 32 ± 1without CO2
L-15 GlutaMAX™ + 10% HI-FBS + 5% TPB
HAE/CTVM9 2.4 × 106 cells/tube(5.5 cm2 flat-sided tubes) 32 ± 1without CO2
L-15/H-Lac + 20% HI-FBS
For characterization of virus replication in tick-derived cells, the cells were seeded in
5.5 cm2 flat-sided tubes (Nunc™, Thermo Fisher Scientific, Swindon, UK) (Table 2) and
infected at a MOI of 1. Virus inoculum was left to adsorb at room temperature for 90 min
and then removed. Cells were washed twice with PBS and 1.5 mL of fresh maintenance
medium was added (Table 2). Supernatant samples (250 µL) were collected immediately
(0 dpi sample) from each tube and fresh replacement medium was added (250 µL). Tubes
were then incubated at +32 ◦C without CO2 for thirty days. Supernatant samples (250 µL)
were collected daily during the first 10 days and subsequently every five or ten days, up
to thirty days pi. Medium was replaced (250 µL) after each sampling. To maintain cell
viability, two-thirds of the medium was changed every 10 days. When a medium change
was carried out, a sample was collected before and after the medium change. All samples
were stored at +4 ◦C until the end of the experiment, when viral RNA was extracted, and
viral genome copies were quantified (as above).
2.3. Virus Titration
End-point titration of virus stocks or selected supernatants were carried out on BSR
cells in 96 well tissue culture plates. Briefly, 100 µL of BSR cells in DMEM containing 1%
FBS (HI) at a density of 3× 105 cells/mL was added to each well. In a separate 96 deep-well
plate, a 10-fold serial dilution (from 10−1 to 10−8) of the virus sample to be titrated was
made in DMEM/1% FBS (HI)/1% Pen/Strep. 100 µL of the 10−1 to the 10−8 virus dilution
series were then transferred into the 96 well plate with cells (rows A to H). Each sample
was tested in quadruplicate (i.e., four columns) and one extra column contained only
media (uninfected control). Cells were incubated for 6 days at +37 ± 1 ◦C with 5% CO2
and the number of infected wells with CPE was recorded. Tissue Culture Infective Dose
(TCID50) values of 50% were calculated using the Karber formula [51]. To calculate MOIs
(MOI = PFU/N◦ of cells), a PFU/mL working estimate was calculated using the formula,
1 TCID50/mL = 0.7 PFU/mL.
2.4. Virus Purification
Purification of rBTV-1 and BTV-26 was adapted from [52]. Briefly, three T175 cm2
flasks (Greiner Bio-One, Monroe, NC, USA) of BSR cells were infected with BTV when
cells were 80%-90% confluent and incubated at +37 ◦C and 5% CO2. When 90 to 100% of
cytopathic effect (CPE) was observed (usually at around 48–72 hpi), cells were harvested
and pelleted by centrifugation at 1912× g and +4 ◦C for 10 min. Supernatants were then
discarded, and cell pellet re-suspended in 10 mL of ice-cold 0.5% Triton-TNE buffer with
1× protease inhibitor cocktail (Sigma-Aldrich®, Gillingham, UK). A cytoplasmic extract
was made using a hand-held glass homogeniser, then centrifuged for 10 min at 1000× g, at
+4 ◦C. Five mL of the extract supernatant was kept on ice until required. The remaining
5 mL of extract was mixed with another 5 mL of 0.5% Triton-TNE with 1× Protease
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Inhibitor Cocktail and the pellet re-suspended. Manual homogenisation and the collection
steps were repeated twice more, giving a final volume of collected cytoplasmic extract
of 20 mL. The pellet was discarded after this. The cytoplasmic extract was layered on a
sucrose gradient consisting of 40% w/v sucrose with 0.1% N-Lauroyl Sarcosine (NLS)/0.2M
Tris-HCl pH 8.0 on top of a 66% w/w sucrose solution, and centrifuged for 2 h in SW28
open tubes (Beckman Coulter, High Wycombe, UK) at 25,000 rpm (rotor Ti32), +4 ◦C and
lowest brake settings. Virus particles were collected from the interface between the two
gradients and re-suspended with 0.1% NLS/0.2 M Tris-HCl pH8.0 buffer. Virus purity
and viral titres (3.88 × 107 PFU/mL for rBTV-1 and 1.7 × 108 PFU/mL for BTV-26) was
confirmed by 10% SDS-PAGE visualised by Pierce silver staining (Thermo Fisher Scientific,
Swindon, UK) and endpoint titration, respectively. Virus preparations were stored at +4 ◦C
until needed.
2.5. Protein Identification by Mass Spectrometry
Sucrose purified BTV-26 was mixed with 3× blue loading dye containing DTT (New
England BioLabs®, Ipswich, MA, USA) as per manufacturer’s instructions. The virus-dye
mixture was then heated at 95 ◦C for 5 min before running it in a 4–20% Criterion™ TGX™
Precast Midi Protein gel (Bio-Rad, Hercules, CA, USA) for 2 h as per manufacturer’s
instructions. Viral protein bands were visualised by Coomassie® blue (Thermo Fisher
Scientific, Swindon, UK), Pierce silver staining or SYPRO® Ruby Protein Gel Stain (Thermo
Fisher Scientific, Swindon, UK). The two bands closest to the expected molecular size
of VP2BTV26 were then excised and kept in ultrapure water at +4 ◦C until sequenced by
mass spectrometry. Briefly, bands were destained and in-gel tryptic digestion performed
essentially as described by [53]. Extracted peptides were reduced to dryness using a
centrifugal vacuum concentrator (Eppendorf, Hamburg, Germany) and re-suspended in
3 % (v/v) methanol, 0.1 % (v/v) TFA for analysis by MS. LC-MS/MS analysis was similar
to that described by [54]. Peptides were analysed by on-line nanoflow LC using the
Ultimate 3000 nano system (Dionex/Thermo Fisher Scientific, Swindon, UK) coupled to a
Q-Exactive mass spectrometer (Thermo Fisher Scientific, Swindon, UK). Spectral data were
analysed using the PEAKS studio X+ software (Bioinformatics Solutions Inc., Waterloo,
ON, Canada, [55]). Tandem MS data were searched against BTV protein database in NCBI
and a contaminant database (cRAP, GPMDB, 2012). Search parameters were as follows;
precursor mass tolerance set to 15 ppm and fragment mass tolerance set to 0.02 Da. Two
missed cleavage events were permitted. Carbamido-methylation (C) was set as a fixed
modification and oxidation (M) and acetylation (N-term) were set as variable modifications.
The search was semi-specific. The false discovery rate was set at 1%.
2.6. Fluorescent Microscopy
Intracellular immune labelling of the viral non-structural protein 2 (NS2) was used to
detect and assess the progress of virus replication over time. Fixed cells on coverslips were
washed three times with calcium and magnesium free Dulbecco’s phosphate buffered saline
(DPBS) and permeabilised for 15 min with 0.1% Triton (Sigma-Aldrich®, Gillingham, UK)
in DPBS. Cells were subsequently incubated with 0.5% bovine serum albumin (BSA)/DPBS
for 30 min at room temperature, followed up by one hour incubation with Orbivirus
reference antibody 1 (Orab1), in-house, rabbit polyclonal antibodies (raised against bacterial
expressed, purified NS2 of BTV-1) diluted 1:2500 in 0.5% BSA/DPBS. Cells were washed
three times with DPBS, before incubating them for one hour with goat anti-rabbit IgG Alexa
Fluor® 488 secondary antibody (Life Technologies Limited, Paisley, UK), diluted 1:250 in
0.5% BSA/DPBS. After another three washes with DPBS, cellular nuclei were stained with
4′, 6-Diamidino-2-phenylindole (DAPI) (Life Technologies Limited, Paisley, UK) for ten
minutes. Finally, coverslips were washed in distilled water, mounted on glass slides on
a drop of Vectashield® mounting medium (Vector Laboratories, Burlingame, CA, USA),
sealed with nail varnish and analysed by confocal microscope (Leica SP8 CLSM, Leica
Microsystems, Wetzlar, Germany).
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The percentage of infected cells was calculated by counting at least five-hundred cells
(nuclei) per area and assessing for NS2 immunofluorescence. In total, three random areas
per coverslip were selected, and two independent experiments were carried out.
2.7. Binding Assay
The ability of BTV-26 to bind KC cells was assessed by immuno-labelling of cell
surface-bound virus. BTV-1 and BSR cells were used as positive controls. Briefly, BSR
(1 × 105 cells) or KC cells (1 × 106 cells) were seeded on 13 mm glass coverslips in 24 well
tissue culture plates (Corning® Costar®, Corning Inc., Corning, NY, USA) and incubated
overnight at +37 or +28 ◦C, respectively. Cells were then placed on ice and washed once
with ice-cold calcium and magnesium free DPBS. Three hundred µL of purified virus
(BTV-26 or BTV-1) was added at a MOI of 50, and cells were incubated on ice for one hour
to allow virus binding to the cell, but not internalization. Inoculum was then removed
and cells washed three times with ice-cold DPBS before fixing them with 4% PFA for
one hour. Fixed cells were then immuno-labelled as described for intracellular immuno-
labelling, but without membrane permeabilization, using primary antibodies targeting
virus particles (structural proteins). In-house guinea-pig Orab279 polyclonal antibody
(anti-BTV-1) or goat GT01 polyclonal antibody (anti-BTV-26) were used, diluted 1:2000 or
1:1000 in 0.5% BSA/DPBS, respectively. Cells were washed three times with DPBS, before
incubating them for one hour with goat anti-guinea pig IgG Alexa Fluor® 488 or donkey
anti-goat IgG Alexa Fluor® 488 secondary antibodies (Life Technologies Limited, Paisley,
UK), diluted 1:250 in 0.5% BSA/DPBS. After another three washes with DPBS, cellular
nuclei were stained with DAPI for ten minutes. Phalloidin conjugated to Alexa Fluor®
633 dye (Life Technologies Limited, Paisley, UK) was used to stain actin filaments, as per
manufacturer’s instructions. Finally, coverslips were washed, mounted and analyzed by
confocal microscopy as described above.
2.8. Transmission Electron Microscopy (TEM)
KC cells at a density of 7 × 105 cells were seeded on 13 mm Thermanox plastic
coverslips (Thermo Fisher Scientific, Swindon, UK) and incubated overnight at +28 ◦C.
Cells were then infected at a MOI of 5 with BTV-1, BTV-26 or rBTV-126 S2,S6,S7 then incubated
at +28 ◦C. At two days pi cells were fixed in phosphate buffered 2% glutaraldehyde (Agar
Scientific Ltd., Stansted, UK) for 1 h followed by 1 h in aqueous 1% osmium tetroxide (Agar
Scientific Ltd., Stansted, UK). The samples were dehydrated in an ethanol series; 70% for
30 min, 90% for 15 min and 100% three times for 10 min each. A transitional step of 10 min
in propylene oxide (Agar Scientific Ltd., Stansted, UK) was undertaken before the samples
were infiltrated with a 50:50 mix of propylene oxide and epoxy resin (Agar Scientific Ltd.,
Stansted, UK) for 1 h. After a final infiltration of 100% epoxy resin for 1 h, the samples
were embedded and polymerised overnight at 60 ◦C. Eighty µm thin sections were cut,
collected onto copper grids (Agar Scientific Ltd., Stansted, UK) and grid stained using
Leica EM AC20 (Leica Microsystems, Wetzlar, Germany) before being imaged at 100 kV in
a FEI Tecnai 12 TEM with a TVIPS F214 digital camera (FEI Company, Hillsboro, OR, USA).
2.9. Oral Infection of Adult Culicoides sonorensis Midges
In-house laboratory-reared adult Culicoides sonorensis midges [56] were fed on BTV-
infected blood meals, as previously described [18,25]. Briefly, approximately 200 two to
three day old adult female C. sonorensis biting midges were deprived of sugar for 24 h, be-
fore being allowed to feed on defibrinated horse blood (TCS Biosciences, Botolph Claydon,
UK) containing 106 or 107 TCID50/mL of BTV, using the Hemotek system (Hemotek Ltd.,
Blackburn, UK) with a Parafilm membrane (Cole-Parmer, Vernon Hills, IL, USA). Immedi-
ately after infection/feeding (0 days post infection (dpi)), 10 membrane-fed C. sonorensis
from each group were individually homogenised in 1 mL of serum-free Schneider’s insect
medium (Sigma-Aldrich®, Gillingham, UK) using 3 mm round metal beads and a Qiagen
Tissue Lyser (Qiagen, Hilden, Germany). The remaining blood-fed insects were incubated
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for 8 days at +25 ± 1 ◦C with access to 10% sucrose diluted in water (on cotton wool pads).
At the end of the incubation period, individual Culicoides midges were homogenized and
RNA was extracted from 100 µL of midge homogenate using a Kingfisher™ Flex robot
and the LSI MagVet™ Universal Isolation Kit (Thermo Fisher Scientific, Swindon, UK) as
per manufacturer’s instructions. Virus levels were measured using a BTV qRT-PCR assay
targeting Seg-9 [50]. Vector competence rates (proportion of midges with transmissible
levels of viral RNA) were calculated as the proportion of midges with significantly higher
amounts of viral RNA at 8 dpi, compared to 0 dpi [25,29,57].
2.10. Statistical Analysis
For all experiments, results were plotted using the GraphPad Prism software version
7.00 (GraphPad Software, San Diego, CA, USA). The specific statistical test carried out is
described in each figure legend. For oral infection of adult C. sonorensis midges, sample size
was calculated prior to the experiments, using a test for two proportions using Minitab,
version 18 (Minitab LLC, State College, PA, USA). Size sample calculated was 95 individuals
for each group, with the following assumptions: power value = 0.8; baseline p = 0.18;
comparison p = 0.05 and significance level = 0.05. Since data from vector competence
studies was not normally distributed, non-parametric tests were chosen to analyse the
data. Comparison of two populations was carried out with Mann Whitney test, while for
comparison of multiple groups, Krustal-Wallis test was used. Vector competence rates
were estimated with 95% confidence intervals using a one-sample proportion test.
3. Results
3.1. BTV-26 KUW2010/02 Is Unable to Replicate in Arthropod-Derived Cells In Vitro
The inability of BTV-26 to infect and replicate in adult Culicoides sonorensis, or the C.
sonorensis-derived KC cell line, which are both susceptible to infection by classical BTV
strains [18,19,58], led us to ask whether BTV-26 could be vectored by other arthropod
species. Our previous study showed low levels of replication of BTV-26 in immune-
deficient C6/36 mosquito cells [19]. Therefore, we also assessed the ability of BTV-26
to replicate in several other arthropod-derived cell lines, including U4.4 cells (derived
from Aedes albopictus mosquitoes), RAE25 cells (from Rhipicephalus appendiculatus ticks) and
HAE/CTVM9 cells (from Hyalomma anatolicum ticks). Host-relevant Bovine Foetal Aorta
endothelium cells (BFA) were included for comparison, as a positive control for effective
viral replication.
Both rBTV-1 and BTV-26 replicated effectively in bovine BFA cells (Figure 1A) plateau-
ing at approximately 109 genome copies/mL between 72 and 96 hpi. Infection of the
mosquito cell line U4.4 with rBTV-1 (Figure 1B) resulted in exponential virus replication
from 2 to 7 dpi, which peaked at approximately 109 genome copies/mL. In contrast,
there was an overall decrease in BTV-26 genome copy numbers in these mosquito cells
(Figure 1B) by the end of the experiment at 10 dpi, compared to the viral inoculum at 0 hpi.
Infection of the tick cell lines RAE25 and HAE/CTVM9 with rBTV-1, or BTV-26 (Figure 1C)
showed no increase in either infectivity or genome copy numbers during the first 10 days
pi. Media changes at 10 and 20 dpi led to some fluctuations of BTV RNA detection in the
collected supernatants (Figure 1C), although overall amounts of viral genome copies still
decreased between 0 and 30 dpi for both BTV-1 and BTV-26 in the tick cell lines RAE25 and
HAE/CTVM9. Overall, these results show that BTV-26 is not able to successfully propagate
in these arthropod-derived cell lines.
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Figure 1. Replication kinetics of BTV-1 and BTV-26 in mammalian and arthropod cell lines. Bovine-BFA cells (A) were
seeded at a density of 1.00 × 105 cells/well. Aedes-U4.4 cells (B) were seeded at a density of 2.50 ×107 cells/flask. In (C),
tick-derived Rhipicephalus appendiculatus-RAE25 cells or Hyalomma anatolicum-HAE/CTVM9 cells were seeded at a density
of 2.40 ×106 cells/tube or 2.00 × 106 cells/tube, respectively. Cells were infected at a MOI of 0.01 (A,B) or 1 (C) with
rBTV-1 (black triangles) or BTV-26 (red circles). Infected BFA cells were incubated at +37 ◦C with CO2, while U4.4 were
incubated at +28 ◦C without CO2 and tick cells at +32 ◦C without CO2. In all panels, 250 µL of supernatant were collected
at each indicated time point. BTV genome copy numbers were determined using the qRT-PCR BTV Seg-9 assay [50] on
extracted RNA and the results are expressed as the mean of genome copies/mL of two independent experiments (A,B) or
one experiment in triplicate (C) ± standard error of the mean. In (C), 50 µL of supernatant were used to calculate 50% tissue
culture infective dose (TCID50/mL) in BSR cells.
3.2. Cell Binding Studies of Purified BTV-26 in Culicoides-Derived Cells
To elucidate the mechanism/s that restrict BTV-26 infection and propagation in arthro-
pod cells, we next started interrogating the replication cycle of BTV-26 in cells derived from
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vector-competent midges (KC cells). The ability of purified BTV-26 virus particles to attach
to Culicoides (KC) and mammalian (BSR) cell-surfaces was first investigated.
Initially, the integrity of purified BTV-1 and BTV-26 particles was tested by elec-
trophoresis in 10% SDS-PAGE gel. The protein migration patterns of purified virus particles
(Figure 2A), showed a band at the size of the sub-core protein VP3 of BTV-26 (94 kDa),
but not at the predicted size of outer-capsid and cell-attachment protein VP2 (111 kDa) of
BTV-26, suggesting that either VP2 and VP3 of BTV-26 (VP2BTV26 and VP3BTV26) co-migrate
under these conditions or that VP2BTV26 might have detached from the particle during the
purification process. However, analysis in a 4%–20% gradient gel (Figure 2B) did show
two bands at ~94 kDa. Subsequent mass spectrophotometry on the two bands confirmed
that VP2BTV26 was present in our purified BTV-26 preparations (Figure 2C), but most likely
migrated faster than VP2BTV1 and below VP3, even though the predicted molecular weight
for both VP2 proteins should be very similar at around 111 kDa, and bigger than their
respective VP3 proteins. This also suggests that VP2 and VP3 of BTV-26 co-migrate in
10% gels.
Figure 2. Protein profile of BTV-26 particles and VP2 identification. Purified particles of rBTV-1 and BTV-26 were run in a
10% SDS-PAGE gel (A) or a 4%–20% Gradient SDS-PAGE gel (B) and stained with SYPRO® Ruby protein gel stain. BTV
particles consists of 3 protein layers: the capsid (VP2 and VP5), the outer core (VP7) and the inner core (VP3). In (A,B),
ladder is Mark12™ Unstained Standard. Sequencing of Bands 1 and 2 (in B) by mass-spectrophotometry identified them as
BTV-26 VP3 and VP2, respectively (C).
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Having confirmed that our BTV-26 had not lost cell attachment protein VP2 during
purification, cell-binding experiments were carried out. Detection of virus bound to the
cell surface confirmed the ability of BTV-26 capsid proteins to mediate attachment to
mammalian BSR cells (Figure 3A). However, BTV-26 particles were not detected on the
surface of KC cells in comparable binding experiments (Figure 3B), indicating that they do
not bind efficiently to these insect cells. As KC cells are smaller in size than mammalian
BSR cells, we demonstrated that visualization of virus particle binding was not affected
by the cell size and that binding of rBTV-1 particles to KC cell membranes was readily
detectable (Figure 3B).
Figure 3. Binding ability of BTV-26 in mammalian and Culicoides midge cells. BSR (A) or KC (B) cells were either mock
infected or infected with purified rBTV-1 (B only) or BTV-26 (A,B) at a MOI of 100 (A) or 50 (B) in ice-cold conditions to
prevent virus internalization. After 60 min, cells were washed three times with ice-cold serum-free medium, fixed with
4% PFA and labelled for DNA (DAPI-blue), Actin (Phalloidin-633, red) and BTV-1 (Orab279-Alexa Fluor 488, green) or
BTV-26 (GT0128-Alexa Fluor 488, green). Cells were visualized by confocal laser scanning microscopy. In (A), the scale bar
represents 20 µm for all panels, while in (B), the scale bar represents 5 µm, and it is a representative image of 3 experiments.
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3.3. The Ability of the BTV-26 Capsid to Block Virus Replication in KC Cells
Having found that BTV-26 is deficient in its ability to bind to the surface of KC cells,
we next investigated if this was mediated solely by its capsid proteins or if conditions such
as temperature and MOI might mitigate the low binding and facilitate viral replication. The
outer-capsid (VP2 and VP5) and outer-core (VP7) proteins of BTV play multiple roles at dif-
ferent stages of the BTV replication cycle. These include cell attachment, internalization of
virus particles, and release of transcriptionally active core-particles into the cell cytoplasm,
as well as later stages such as assembly and release of progeny virus particles [59].
KC cells were infected at a low MOI (0.01 TCID50/cell) at 27 ◦C with parental strains
BTV-26 or rBTV-1, and virus release into the supernatant was measured up to 10 days pi. A
reverse engineered virus (rBTV-126 S2,S6,S7) containing three major capsid and core proteins,
VP2, VP5 and VP7 derived from BTV-26, in a BTV-1 genetic backbone (Table 1, [19]), was
also included in these experiments. Although, as previously shown [19], rBTV-1 replicated
and was amplified in KC cells, BTV-26 and rBTV-126 S2,S6,S7 failed to propagate effectively,
with viral-genome copy numbers increasing only slightly in the supernatant between days
0 and 2 pi, then remaining unchanged for the rest of the experiment (Figure 4). Next, we
investigated whether increasing the MOI 100-fold (MOI of 1) would overcome any obstacle
to replication and propagation caused by for example, an inefficient cell-entry process.
However, at this MOI, BTV-26 and rBTV-126 S2,S6,S7 still failed to replicate efficiently or
spread in KC cell cultures at 27 ◦C, with only a minor increase in supernatant genome copy
numbers between 0 and 2 dpi (from ~106 to ~107 copies/mL), which then remained “flat”
until 10 dpi (Figure 4).
Figure 4. Replication kinetics of rBTV-1, BTV-26 and rBTV-126 S2,S6,S7 in Culicoides cells under several conditions. KC cells
were seeded at a density of 7.00 × 105 cells/well on coverslips, and infected at a MOI of 0.01 or 1, with rBTV-1 (black
triangles), BTV-26 (red circles) or rBTV-126 S2,S6,S7 (blue squares). Infected cells were incubated at +27 ◦C or 37 ◦C without
CO2. Two hundred and fifty µL of supernatant were collected at each indicated time point, and total RNA extracted from
100 µL of supernatant. BTV genome copy numbers were determined using the qRT-PCR BTV Seg-9 assay [50]. Results are
expressed as the mean of genome copies/mL of two independent experiments ± standard error of the mean.
BSR and KC cell cultures are usually grown at 37 ◦C and 27 ◦C, respectively. Infection
of KC cells with rBTV-1 at 37 ◦C resulted in faster replication than at 27 ◦C, plateauing after
3 dpi instead of at 7dpi (Figure 4). However, when KC cells were infected at 37 ◦C with
BTV-26, or rBTV-126 S2,S6,S7, there was no significant increase in virus copy numbers up to
10 dpi, with kinetics very similar to infections at 27 ◦C, indicating that both viruses again
failed to replicate and amplify successfully.
3.4. The Capsid of BTV-26 Blocks the Early Stages of Virus Replication Cycle in KC Cells
BTV non-structural protein 2 (NS2) is synthesized soon after the virus core enters the
cell cytoplasm and initiates viral mRNA synthesis [60]. NS2 can therefore be used as a
marker for the early stages of replication, indicating that cell-entry, mRNA synthesis and
translation have occurred. NS2 was detected at 2 dpi in 4.6% of KC cells infected with
rBTV-1 at a low MOI of 0.01, increasing to 67% of cells at 4 dpi (Figure 5A,B), showing that
the virus had successfully entered the cells, initiated mRNA and protein synthesis, and
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was spreading effectively to other cells. In contrast, NS2 was detected in <0.05% of KC cells
infected with BTV-26 at either 2 or 4 dpi, confirming that infection and virus replication are
severely restricted (Figure 5A,B).
Figure 5. Intracellular replication of rBTV-1, BTV-26 and rBTV-126 S2,S6,S7 in Culicoides cells. KC cells were seeded at a
density of 7.00E+05 cells/well on coverslips in a 24-well plate at a low MOI of 0.01 (A,B). At 2 or 4 days pi cells were fixed
with 4% PFA and labelled for DNA (DAPI, in blue) and viral NS2 (Orab1-Alexa Fluor 488, in green). Cells were visualized
by confocal laser scanning microscopy (A) and the percentage of NS2 positive cells from two independent experiments
calculated (over 3000 cells counted) (B). In (A), the scale bar represents 10 µm for all panels. In (C), a comparison of
the percentage of NS2 positive cells at 2 dpi between KC cells infected at low (L) MOI (0.01) or high (H) MOIs (1–5) is
shown. Means were compared by carrying out ANOVA tests: a Sidak’s multiple comparison test (B) or a Tukey’s multiple
comparison test (C).
However, low numbers of KC cells did become infected with rBTV-126 S2,S6,S7 at
an MOI of 0.01, with NS2 detected at both 2 and 4 dpi (in 1% and 0.75% of the cells,
respectively) (Figure 5A,B), suggesting that a low level of cell entry and initiation of
viral RNA transcription and protein translation had been achieved, but infection did not
progress or spread to additional cells over this time period. With a 100-fold increase of the
MOI (MOI of 1 or 5) (Figure 5C), NS2 was still undetected in KC cells infected with BTV-26.
However, a slight increase in the number of cells expressing NS2 (2.92 %) was observed at
2dpi with rBTV-126 S2,S6,S7. Together with the results already described (Figures 3 and 4),
this indicates that early stages of the viral replication cycle are strongly restricted by the
capsid proteins of BTV-26, although if this block is overcome, at least some of the later
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stages of virus replication can proceed, albeit seemingly not resulting in significant spread
of infection to other cells.
Transmission Electron Microscopy (TEM) of pelleted KC cells infected at an MOI of 5
with rBTV-1, BTV-26 or rBTV-126 S2,S6,S7 (Figure 6), confirmed that a few cells were actively
infected with rBTV-126 S2,S6,S7 at 2 dpi. These cells contained viral inclusion bodies (VIBs),
(composed of NS2), viral ‘tubules’ (composed of NS1) and newly assembled core particles
in the cell cytoplasm, demonstrating that viral mRNA/protein synthesis and core particle
assembly had occurred. However, whole virus particles were not seen in these infected
cells, suggesting that there might be other blocks late in the replication and assembly
pathway of rBTV-126 S2,S6,S7 in KC cells, again possibly mediated by VP2 of BTV-26.
Figure 6. Transmission electron microscopy (TEM) of Culicoides cells infected with rBTV-1, BTV-26 or rBTV-126 S2,S6,S7. KC
cells on coverslips were either mock infected or infected at a MOI of 5 and incubated at +27 ◦C with rBTV-1, BTV-26, or
rBTV-126 S2,S6,S7. At 2 dpi, cells were fixed with phosphate buffered 2% glutaraldehyde. Cells were visualised by TEM (FEI
Tecnai 12 TEM with a TVIPS F214 digital camera). Open arrows show whole virus particles (only in rBTV-1), arrows show viral
core particles, ovals show viral inclusion bodies (VIBs) made of NS2, and diamonds show viral microtubules made of NS1.
VIBs, NS1 tubules, or core particles were not observed in KC cells infected at a high
MOI with BTV-26. When internalization of a few BTV-26 particles could occur (as suggested
by the data with rBTV-126 S2,S6,S7), both immunofluorescence staining and TEM failed to
detect replication of BTV-26. This suggests additional blocks to virus replication mediated
by other proteins of BTV-26 such as VP1, or VP3 of BTV-26 [19].
3.5. Capsid Proteins of BTV-26 Restrict BTV Replication in Adult C. sonorensis
The biological importance of the in vitro results presented was assessed by orally
infecting adult female Culicoides sonorensis midges, with blood meals containing rBTV-1,
BTV-26 or rBTV-126 S2,S6,S7. Virus replication was measured at 8 days post feeding (dpf),
and vector competence ratios were determined as previously described [25].
Initial infections of C. sonorensis adults with 106 TCID50 of virus/mL of blood (a
viral load similar to the average peak viraemia in an infected ruminant) revealed a low
competence rate for rBTV-1 (1.39%) (Figure S1a), suggesting that the reverse engineered
rBTV-1 was a poor positive control for infection. Direct comparison with other BTV-1
strains and conditions of infection (Figure S1) showed that the vector competence of C.
sonorensis for rBTV-1 was significantly lower than for the reference strain (RSArrrr/01)
(identified here as wild type (wt) BTV-1). Interestingly, passage of rBTV-1 in KC cells
(rBTV-1 KC) prior to infecting C. sonorensis increased viral replication efficiency of this
“synthetic” virus within the vector insects. Although beyond the scope of this study, this
suggests a role for viral variants and strain-diversity in infection and replication efficiency.
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As rBTV-1 (BSR cell passaged) was, however, needed as matched positive control
for BTV 26 and rBTV-126 S2,S6,S7, we investigated whether the vector competence rate of C.
sonorensis for rBTV-1 could be increased by raising the viral dose in the blood meal [39].
Orally infecting C. sonorensis midges with a 10-fold increase in the amount of rBTV-1
showed a significant increase in vector competence rate (Figure S1d,e). Therefore, subse-
quent infections of adult midges with BTV-26 and rBTV-126 S2,S6,S7 were carried out using
blood meals containing 107 TCID50/mL of virus.
Analysis of midges orally infected with blood containing 107 TCID50/mL of rBTV-1
(Figure 7A) showed that 139 out of 140 individuals (99.29%) contained detectable levels
of viral RNA (vRNA) on day 8 pf. Midges that were positive for vRNA, could be divided
into two significantly different subpopulations, which we identified as “competent” and
“non-competent” based on significantly higher or lower amounts of vRNA compared to
levels in midges at 0 dpf (Median Ctcompetent = 19.02 vs: Ctday0 = 24.30, p ≤ 0.001: Median
Ctnon-competent = 33.55 vs: Ctday0 = 24.30, p ≤ 0.001). Twenty-six midges had higher vRNA
levels than midges on day 0 pf, indicating that 18.56% (95% CI: 12.50–26.01%) of the midges
were vector-competent for rBTV-1.
Figure 7. Oral infection of adult Culicoides sonorensis midges with rBTV-1, BTV-26 and rBTV-126 S2,S6,S7. Plotted results for 0
and 8 dpi of adult female C. sonorensis orally infected with 107 TCID50/mL of (A) rBTV-1; (B) BTV-26; and (C) rBTV-126 S2,S6,S7.
In (A–C) dotted lines show the threshold that indicates viral levels of transmissibility/vector competence. Box-and-whiskers
show median (line), 1st and 3rd quartiles (25th and 75th percentiles) of the different determined populations (Whiskers
were defined by the Tukey method, and comparison of medians by Mann-Whitney test). Comparison of all groups at 8 dpi
is shown in (D), where calculated competence rates are shown as percentages (2 proportions comparison-Minitab). In all
panels each symbol represents one individual midge.
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None of the surviving 103 midges fed with BTV-26 at 107 TCID50/mL (Figure 7B)
had viral RNA levels at 8 dpf above those at 0 dpf, indicating a competence rate of 0%
(95% CI: 0–2.87%). The median Ct for the 10 RNA positive but non-competent midges
(Median Ctnon-competent = 37.74) was significantly higher (p ≤ 0.001) than that on 0 dpf
(Ctday0= 29.26).
None of the 144 midges that were orally infected with rBTV-126 S2,S6,S7 had levels of
vRNA on 8 dpf that indicated virus replication to transmissible levels (Figure 7C). Thirty-six
midges had low vRNA levels at 8 dpf, significantly below values on 0 dpf (Ctday0 = 28.23,
p ≤ 0.001), identifying them as non-competent (Median Ctday8 = 37.67). This confirms that
the capsid proteins of BTV-26 not only restrict viral infection and replication in Culicoides
cells in vitro, but also restrict BTV replication in adult BTV-competent C. sonorensis midges.
4. Discussion
The work presented shows that replication of the ‘atypical’ BTV-26 (strain KUW2010/02)
is severely restricted in numerous arthropod cells (results summarized in Table 3), including
cells derived from the BTV-vector spp. Culicoides sonorensis (KC cells), as well as in adult
C. sonorensis midges. We show for the first time that the inability of BTV-26 to complete
its replication cycle in KC cells starts with a block in the early stages of its replication,
including a greatly reduced ability of the virus to bind to the surface of KC cells. This block
is mediated by capsid proteins of BTV-26, preventing amplification and propagation of the
virus in vivo within the insect-vector.
Table 3. Summary of the ability of rBTV-1 and BTV-26 to replicate in several mammalian and
arthropod-derived cell lines.
Cell Line/Organism rBTV-1 BTV-26 rBTV-126S2, S6, S7
BSR (Hamster–fibroblasts) + + + 1
BFA (Bovine–aorta endothelium) + + NA
KC (C. sonorensis midge–larvae) + - -
U4.4 (A. albopictus mosquito–) + - NA
RAE25 (R. appendiculatus tick–) - - NA
HAE/CTVM9 (H. anatolicum tick–) - - NA
Adult C. sonorensis midges + - -
“+” indicates efficient replication, whereas “-” indicates severely deficient or no replication at all; 1 in [19].
The BTV outer-capsid is composed of the two most variable virus proteins (VP2 and
VP5), which are involved in cell attachment (via VP2) and penetration of the cell membrane
(via VP5), during the early stages of infection by intact virus particles in both mammalian
and insect cells [37]. BTV core particles that have lost their outer coat proteins VP2 and
VP5 can also initiate cell entry in KC cells, and less efficiently in some mammalian cells
(e.g., BHK but not CHO (Chinese Hamster Ovary cells)), mediated by the core-surface
protein VP7 [39,52]. Our previous research showed that mono-reassortant BTV-1 viruses
containing either VP5 or VP7 derived from BTV-26 can replicate in both KC and BSR cells,
while BTV-26 and rBTV-126 S2,S6,S7 can replicate in mammalian BSR cells but not in KC cells
(this study and [19]). We therefore conclude that the failure of rBTV-126 S2,S6,S7 to infect and
replicate in Culicoides cells is most likely due to VP2 of BTV-26.
Although not strictly quantitative and potentially missing low frequency events,
confocal microscopy suggests that BTV-26 is largely unable to attach to the C. sonorensis
cell-membranes, mediated by VP2BTV26. This represents a major barrier to cell-entry and
infection, preventing productive replication, demonstrated by a failure to detect NS2
synthesis by BTV-26 in KC cell. The cell-receptors for BTV binding have not yet been
identified in either mammalian or insect cells, although there is evidence to suggest that
BTV uses different entry pathways and therefore possibly different receptors, depending
on serotype, target cell and viral particle type [35,36,38,40,52].
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However, BTV-26 does bind to permissive mammalian BSR, or bovine BFA cells, in
both cases leading to infection and amplification of the virus genome. This confirms that
VP2 of BTV-26 is a fully functional mammalian-cell-attachment protein. Protein sequencing
by mass spectrometry confirmed the presence of VP2 in purified BTV-26 particles, as well
as suggesting that it migrates faster on SDS-PAGE gels than VP2BTV-1, even though both
proteins have a similar predicted size, and no obvious differences in hydrophobicity and
charge (using https://www.expasy.org/resources/protparam, accessed on 25 February
2021). Whether there are still differences in their folding and/or post-translation modifica-
tions, which could potentially also explain differences in their cell attachment properties,
needs to be further investigated.
A small number of KC cells did become infected with rBTV-126 S2,S6,S7, resulting in
viral protein synthesis and at least the early stages of replication and particle assembly,
generating VIBs, tubules and core particles, as detected by TEM. In contrast to rBTV-1, fully
intact virus particles were not identified in the cytoplasm of rBTV-126 S2,S6,S7 infected KC
cells, although the very small percentage of cells infected by this reassortant virus limits
the conclusions that can be drawn by TEM. This low level of infection might reflect binding
and entry of alternative particle types (e.g., core particles or membrane enveloped virus
particles (MEVP) [61]) that are likely to be present in tissue culture-derived virus stocks).
In addition to a block in the initial stages of cell binding and entry, the failure of rBTV-
126 S2,S6,S7 to spread to other cells in KC cultures might reflect additional blocks to either the
final assembly of the outer-capsid of progeny virus particles, or a failure of any intact virus
particles generated to be released from infected cells, processes that would both involve
VP2 of BTV-26, as well as its effective interactions with internal components/proteins of
the insect cells [62–65].
In summary, our results support the hypothesis that C. sonorensis is not able to act
as a vector for BTV-26 KUW2010/02, and that BTV-26 might not be a vector-borne virus.
Together with previous evidence of direct-contact transmission [18,21], our results provide
further critical evidence that direct-contact rather than insect vectors constitute its main
route of transmission Further research is required to determine if this applies to other
strains of atypical BTV serotypes [20,66] or if they could be vectored by other arthropods,
including other Culicoides species. VP2 is the most variable BTV protein and the respective
VP2s of the BTV-1 and BTV-26 strain utilized in this study only share 38.5% similarity
in their aa sequence (GenBank accession numbers BTV-1 VP2: FJ969720.1/BTV-26 VP2:
HM590642.1). Furthermore, only recently have some parts of the overall VP2 structure
of BTV-1 been modelled and proposed [37,67]. Nonetheless, further work on VP2BTV26
could focus on identifying domains, motifs, residues, and cell surface proteins involved
in binding of VP2BTV26 to mammalian cells and its inability to bind to KC cells [37,67,68].
This could potentially also shed light on viral genetic determinants required for direct-
contact transmission.
Results presented here highlight the importance of studying the atypical BTV strains,
despite their low pathogenicity, as they can exchange genome-segments (reassort) with
conventional BTV strains, generating novel progeny viruses with unpredictable phenotypes.
This could potentially result in the emergence of economically significant BTV strains
that do not require vectors for transmission, potentially extending their seasonal and
geographic range. The atypical BTV strains, “engineered” reassortant viruses and KC cells
provide useful tools to address questions relating to BTV/vector interactions, cell tropism,
transmission mechanisms and determinants of virulence. With the recent detection of
additional atypical serotypes [16,43], their epidemiological importance and occurrence
appears to be greater than initially anticipated.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/v13050919/s1, Figure S1: Oral infection of adult Culicoides sonorensis midges with different
variants of BTV-1.
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